Myelodysplastic-myeloproliferative diseases
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Myelodysplastic-myeloproliferative diseases Classification and external resources | |
| MeSH | D054437 |
|---|---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Myelodysplastic-myeloproliferative diseases are a category of hematological malignancies disorders created by the World Health Organization which have characteristics of both myelodysplastic and myeloproliferative conditions.
External links
- http://www.meb.uni-bonn.de/cancer.gov/CDR0000334473.html
- http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_myelodysplastic_syndrome_65.asp
- http://www.cancer.gov/cancertopics/pdq/treatment/mds-mpd/Patient
WikiDoc Research Resources for Myelodysplastic-myeloproliferative diseases | |
|---|---|
| Articles on Myelodysplastic-myeloproliferative diseases | Most recent articles on Myelodysplastic-myeloproliferative diseases • Most cited articles on Myelodysplastic-myeloproliferative diseases • Review articles on Myelodysplastic-myeloproliferative diseases • Articles on Myelodysplastic-myeloproliferative diseases in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Myelodysplastic-myeloproliferative diseases | Powerpoint slides on Myelodysplastic-myeloproliferative diseases • Images of Myelodysplastic-myeloproliferative diseases • Photos of Myelodysplastic-myeloproliferative diseases • Podcasts & MP3s on Myelodysplastic-myeloproliferative diseases • Videos on Myelodysplastic-myeloproliferative diseases |
| Evidence Based Medicine Regarding Myelodysplastic-myeloproliferative diseases | Cochrane Collaboration on Myelodysplastic-myeloproliferative diseases • Bandolier on Myelodysplastic-myeloproliferative diseases • TRIP on Myelodysplastic-myeloproliferative diseases |
| Cost Effectiveness of Myelodysplastic-myeloproliferative diseases | Cost Effectiveness of Myelodysplastic-myeloproliferative diseases |
| Clinical Trials Involving Myelodysplastic-myeloproliferative diseases | Ongoing Trials on Myelodysplastic-myeloproliferative diseases at Clinical Trials.gov • Trial results on Myelodysplastic-myeloproliferative diseases • Clinical Trials on Myelodysplastic-myeloproliferative diseases at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Myelodysplastic-myeloproliferative diseases | US National Guidelines Clearinghouse on Myelodysplastic-myeloproliferative diseases • NICE Guidance on Myelodysplastic-myeloproliferative diseases • NHS PRODIGY Guidance • FDA on Myelodysplastic-myeloproliferative diseases • CDC on Myelodysplastic-myeloproliferative diseases |
| Textbook Information on Myelodysplastic-myeloproliferative diseases | Books and Textbook Information on Myelodysplastic-myeloproliferative diseases |
| Pharmacology Resources on Myelodysplastic-myeloproliferative diseases | Dosing of Myelodysplastic-myeloproliferative diseases • Drug interactions with Myelodysplastic-myeloproliferative diseases • Side effects of Myelodysplastic-myeloproliferative diseases • Allergic reactions to Myelodysplastic-myeloproliferative diseases • Overdose information on Myelodysplastic-myeloproliferative diseases • Carcinogenicity information on Myelodysplastic-myeloproliferative diseases • Myelodysplastic-myeloproliferative diseases in pregnancy • Pharmacokinetics of Myelodysplastic-myeloproliferative diseases • |
| Genetics, Pharmacogenomics, and Proteinomics of Myelodysplastic-myeloproliferative diseases | Genetics of Myelodysplastic-myeloproliferative diseases • Pharmacogenomics of Myelodysplastic-myeloproliferative diseases • Proteomics of Myelodysplastic-myeloproliferative diseases |
| Newstories on Myelodysplastic-myeloproliferative diseases | Myelodysplastic-myeloproliferative diseases in the news • Be alerted to news on Myelodysplastic-myeloproliferative diseases • News trends on Myelodysplastic-myeloproliferative diseases |
| Commentary on Myelodysplastic-myeloproliferative diseases | Blogs on Myelodysplastic-myeloproliferative diseases |
| Patient Resources on Myelodysplastic-myeloproliferative diseases | Patient resources on Myelodysplastic-myeloproliferative diseases • Discussion groups on Myelodysplastic-myeloproliferative diseases • Patient Handouts on Myelodysplastic-myeloproliferative diseases • Directions to Hospitals Treating Myelodysplastic-myeloproliferative diseases • Risk calculators and risk factors for Myelodysplastic-myeloproliferative diseases |
| Healthcare Provider Resources on Myelodysplastic-myeloproliferative diseases | Symptoms of Myelodysplastic-myeloproliferative diseases • Causes & Risk Factors for Myelodysplastic-myeloproliferative diseases • Diagnostic studies for Myelodysplastic-myeloproliferative diseases • Treatment of Myelodysplastic-myeloproliferative diseases |
| Continuing Medical Education (CME) Programs on Myelodysplastic-myeloproliferative diseases | CME Programs on Myelodysplastic-myeloproliferative diseases |
| International Resources on Myelodysplastic-myeloproliferative diseases | Myelodysplastic-myeloproliferative diseases en Espanol • Myelodysplastic-myeloproliferative diseases en Francais |
| Business Resources on Myelodysplastic-myeloproliferative diseases | Myelodysplastic-myeloproliferative diseases in the Marketplace • Patents on Myelodysplastic-myeloproliferative diseases |
| Informatics Resources on Myelodysplastic-myeloproliferative diseases | List of terms related to Myelodysplastic-myeloproliferative diseases |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
